|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United Statesand Rest of the World, of which United States generates majority of the revenue. |
| 公司地址
| 1000 Spring Street, Silver Spring, MD, USA, 20910 |
| 電話號碼
| +1 301 608-9292 |
| 傳真號碼
| +1 301 608-9291 |
| 公司網頁
| https://www.unither.com |
| 員工數量
| 1400 |
| Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD |
Chairperson of the Board and Chief Executive Officer |
美元 1.51M |
25/02/2026 |
| Mr. Paul A. Mahon,J.D. |
Executive Vice President, General Counsel and Corporate Secretary |
美元 940.00K |
25/02/2026 |
| Mr. James C. Edgemond |
Chief Financial Officer, Principal Accounting Officer and Treasurer |
美元 860.58K |
25/02/2026 |
| Mr. Michael Benkowitz |
President and Chief Operating Officer |
美元 1.19M |
25/02/2026 |
|
|
| Mr. Christopher Patusky,J.D. |
Vice Chairman of the Board and Lead Independent Director |
25/02/2026 |
| Dr. Louis W. Sullivan, M.D. |
Independent Director |
25/02/2026 |
| Mr. Raymond Dwek,F.R.S. |
Independent Director |
25/02/2026 |
| Mr. Raymond C. Kurzweil |
Independent Director |
25/02/2026 |
| Mr. Kevin J. Tracey, M.D. |
Director |
22/01/2026 |
| Governor Tommy G. Thompson, J.D. |
Independent Director |
25/02/2026 |
| Mr. Christopher Causey,M.B.A. |
Independent Director |
25/02/2026 |
| Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD |
Chairperson of the Board and Chief Executive Officer |
25/02/2026 |
| Mr. Richard Giltner |
Independent Director |
25/02/2026 |
| Ms. Jan Malcolm |
Independent Director |
25/02/2026 |
| Dr. Judy D. Olian, PhD |
Independent Director |
25/02/2026 |
| Ms. Nilda Mesa, J.D. |
Independent Director |
25/02/2026 |
| Dr. Linda Maxwell, M.B.A.,M.D. |
Independent Director |
25/02/2026 |
|
|
|
|
